Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Cardioncology: state of the heart.

Todaro MC, Oreto L, Qamar R, Paterick TE, Carerj S, Khandheria BK.

Int J Cardiol. 2013 Sep 30;168(2):680-7. doi: 10.1016/j.ijcard.2013.03.133. Epub 2013 Apr 30. Review.

PMID:
23639459
2.

Assessment of cardiotoxicity with cardiac biomarkers in cancer patients.

Cardinale D, Cipolla CM.

Herz. 2011 Jun;36(4):325-32. doi: 10.1007/s00059-011-3453-4.

PMID:
21562775
3.

Predicting and preventing cardiotoxicity in the era of breast cancer targeted therapies. Novel molecular tools for clinical issues.

Zambelli A, Della Porta MG, Eleuteri E, De Giuli L, Catalano O, Tondini C, Riccardi A.

Breast. 2011 Apr;20(2):176-83. doi: 10.1016/j.breast.2010.11.002. Epub 2010 Dec 13. Review.

PMID:
21146409
4.

Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management.

Yeh ET, Bickford CL.

J Am Coll Cardiol. 2009 Jun 16;53(24):2231-47. doi: 10.1016/j.jacc.2009.02.050. Review.

5.

Cardiotoxicity of molecularly targeted agents.

Hedhli N, Russell KS.

Curr Cardiol Rev. 2011 Nov;7(4):221-33. Review.

6.

Cardiovascular toxicity caused by cancer treatment: strategies for early detection.

Altena R, Perik PJ, van Veldhuisen DJ, de Vries EG, Gietema JA.

Lancet Oncol. 2009 Apr;10(4):391-9. doi: 10.1016/S1470-2045(09)70042-7. Review.

PMID:
19341970
7.

Clinical vignettes: integrated care of cancer patients by oncologists and cardiologists.

Hofstatter E, Saadati H, Russell K, Russell R 3rd.

Curr Cardiol Rev. 2011 Nov;7(4):258-61.

8.

Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention.

Albini A, Pennesi G, Donatelli F, Cammarota R, De Flora S, Noonan DM.

J Natl Cancer Inst. 2010 Jan 6;102(1):14-25. doi: 10.1093/jnci/djp440. Epub 2009 Dec 10. Review.

9.

Biological drugs: classic adverse effects and new clinical evidences.

Della Pina P, Vizzardi E, Raddino R, Gavazzoni M, Caretta G, Gorga E, Dei Cas L.

Cardiovasc Toxicol. 2012 Dec;12(4):285-97. doi: 10.1007/s12012-012-9173-z. Review.

PMID:
22661099
10.

Chemotherapy-related cardiotoxicity.

Aggarwal S, Kamboj J, Arora R.

Ther Adv Cardiovasc Dis. 2013 Apr;7(2):87-98. doi: 10.1177/1753944712474332. Epub 2013 Mar 13. Review.

PMID:
23487044
11.

Timely recognition of cardiovascular toxicity by anticancer agents: a common objective of the pharmacologist, oncologist and cardiologist.

Bonura F, Di Lisi D, Novo S, D'Alessandro N.

Cardiovasc Toxicol. 2012 Jun;12(2):93-107. doi: 10.1007/s12012-011-9141-z. Review.

PMID:
21894547
12.

[Cardiovascular complications of chemotherapy].

Tovena DM, Inzoli A, Donato G, Gazzaniga P, Bianchessi C.

G Ital Cardiol (Rome). 2012 Oct;13(10 Suppl 2):165S-170S. doi: 10.1714/1167.12943. Italian.

PMID:
23096398
13.

Cancer treatment-induced cardiotoxicity: a cardiac stem cell disease?

Prezioso L, Tanzi S, Galaverna F, Frati C, Testa B, Savi M, Graiani G, Lagrasta C, Cavalli S, Galati S, Madeddu D, Lodi Rizzini E, Ferraro F, Musso E, Stilli D, Urbanek K, Piegari E, De Angelis A, Maseri A, Rossi F, Quaini E, Quaini F.

Cardiovasc Hematol Agents Med Chem. 2010 Jan;8(1):55-75. Review.

PMID:
20210776
14.

Chemotherapy-induced cardiotoxicity: detection, prevention, and management.

Truong J, Yan AT, Cramarossa G, Chan KK.

Can J Cardiol. 2014 Aug;30(8):869-78. doi: 10.1016/j.cjca.2014.04.029. Epub 2014 May 4. Review.

PMID:
25064580
15.

Pharmacological foundations of cardio-oncology.

Minotti G, Salvatorelli E, Menna P.

J Pharmacol Exp Ther. 2010 Jul;334(1):2-8. doi: 10.1124/jpet.110.165860. Epub 2010 Mar 24.

16.

Newest echocardiographic techniques for the detection of cardiotoxicity and heart failure during chemotherapy.

Sawaya H, Plana JC, Scherrer-Crosbie M.

Heart Fail Clin. 2011 Jul;7(3):313-21. doi: 10.1016/j.hfc.2011.03.003. Review.

PMID:
21749883
17.

Strategies to prevent and treat cardiovascular risk in cancer patients.

Cardinale D, Bacchiani G, Beggiato M, Colombo A, Cipolla CM.

Semin Oncol. 2013 Apr;40(2):186-98. doi: 10.1053/j.seminoncol.2013.01.008. Review.

PMID:
23540744
18.

Cardiovascular toxicity of biologic agents for cancer therapy.

Bhave M, Akhter N, Rosen ST.

Oncology (Williston Park). 2014 Jun;28(6):482-90. Review.

19.

The importance of clinical grading of heart failure and other cardiac toxicities during chemotherapy: updating the common terminology criteria for clinical trial reporting.

Hossain A, Chen A, Ivy P, Lenihan DJ, Kaltman J, Taddei-Peters W, Remick SC.

Heart Fail Clin. 2011 Jul;7(3):373-84. doi: 10.1016/j.hfc.2011.03.008. Epub 2011 May 20.

PMID:
21749889
20.

Antineoplastic drug-induced bradyarrhythmias.

Minoia C, Giannoccaro M, Iacobazzi A, Santini D, Silvestris N, Fioretti A, Oliva S, Guarini A.

Expert Opin Drug Saf. 2012 Sep;11(5):739-51. doi: 10.1517/14740338.2012.705826. Epub 2012 Jul 13. Review.

PMID:
22788850
Items per page

Supplemental Content

Write to the Help Desk